Work

A phase Ib/II study of atezolizumab plus tivozanib in pancreatic, gallbladder, and bile duct malignancies.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.4_suppl.tps625

Authors: Brian Hemendra Ramnaraign, Ji-Hyun Lee, Azka Ali, Sherise C. Rogers, Jesus C. Fabregas, Ryan M. Thomas, Carmen Joseph Allegra, David L. DeRemer, Thomas J. George, Jonathan Alexander Chatzkel

Institutions: University of Florida, UF Health Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W4317891387

Cites:

Cited by:

Related to: 10